Shire News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.10.23	Takeda Settles Tax Dispute With Irish Revenue Commissioners Over Break Fee Received By Shire (RTTNews)
14.05.19	Takeda FY18 Profit Down, Revenues Climb (RTTNews)
09.05.19	Takeda To Sell Dry Eye Drug, Surgical Patch To Novartis, J&J For Up To $5.7 Bln (RTTNews)
30.01.19	Equiniti Manages Settlement Of Takeda-Shire Deal - Quick Facts (RTTNews)
22.01.19	Takeda Reportedly Considers Sale Of $3 Billion In Emerging-Market Assets (RTTNews)
17.12.18	Form 8.3 - The Vanguard Group, Inc.: Shire plc (EQS Group)
17.12.18	Shire Announces FDA Approval For Motegrity - Quick Facts (RTTNews)
05.12.18	Shire Shareholders Approve Takeda Deal - Quick Facts (RTTNews)
05.12.18	Takeda Shareholders Approve Resolutions Related To Proposed Acquisition Of Shire (RTTNews)
30.11.18	Shire Granted Marketing Authorisation In EU For TAKHZYRO - Quick Facts (RTTNews)
26.11.18	Biotech Stocks Facing FDA Decision In December (RTTNews)
16.11.18	Form 8.3 - The Vanguard Group, Inc.: Shire plc (EQS Group)
16.11.18	Shire Plc Reports Promising Data From HELP Extension Study With Lanadelumab (RTTNews)
16.11.18	Shire Announces New HELP Study(TM) Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific Meeting (GlobeNewswire)
13.11.18	Shire: FDA To Review SNDA To Extend Indication Of GATTEX - Quick Facts (RTTNews)
25.10.18	Shire Files Submission For FDA Approval To Manufacture Flexbumin At Georgia Site (RTTNews)
19.10.18	Shire: CHMP Recommends EU Marketing Authorisation Of Lanadelumab (RTTNews)
18.10.18	Takeda's Proposed Deal To Buy Shire Gets Japan Fair Trade Commission Clearance (RTTNews)
28.09.18	Biotech Stocks Facing FDA Decision In October (RTTNews)
14.09.18	Takeda Receives China Approval For Proposed Acquisition Of Shire (RTTNews)
12.09.18	Shire: VEYVONDI Gets EU Approval To Treat Von Willebrand Disease In Adults (RTTNews)
06.09.18	Shire Plc To Acquire Sanaplasma AG - Quick Facts (RTTNews)
31.08.18	Shire Closes Sale Of Oncology Franchise - Quick Facts (RTTNews)
24.08.18	Shire Announces Tender Offers For Up To $2.25 Bln Principal Amount Of Notes (RTTNews)
24.08.18	Shire: FDA Approves TAKHZYRO Injection (RTTNews)
19.08.18	Week Ahead In Pharmaceuticals: 7 Stocks To Watch (TNXP, REGN, KALA...) (RTTNews)
01.08.18	APLS To Report Data In 2H, CUR Abuzz, Shire Discontinues NASH Trial (RTTNews)
31.07.18	Shire Q2 Results Beat View; Backs 2018 Outlook (RTTNews)
26.07.18	Biotech Stocks Facing FDA Decision In August (RTTNews)
21.06.18	Shire Reports FDA Approval For Label Expansion Of CINRYZE - Quick Facts (RTTNews)
08.06.18	Takeda Announces Loan Credit Deal, Amendment To Bridge Credit Deal On Shire Deal (RTTNews)
06.06.18	Shire launches screen responsibly, an eyelove® initiative dedicated to prioritizing eye health in a screen-saturated world (PR Newswire)
15.05.18	Shire Recognizes MPS Awareness Day 2018 with Digital Campaign and Global Events Focused on Increasing Diseases Awareness (PR Newswire)
08.05.18	Takeda Pharma To Buy Shire In GBP 46 Bln Cash, Stock Deal - Quick Facts (RTTNews)
06.05.18	Report : Takeda Sees In Shire A Key To New Drug Discovery (RTTNews)
26.04.18	Shire Q1 Results Beat View; Backs 2018 Profit View (RTTNews)
25.04.18	Takeda Raises Offer For Shire To GBP 49/shr (RTTNews)
24.04.18	Takeda Confirms Revised Takeover Proposal For Shire (RTTNews)
24.04.18	Shire Board Receives Revised Proposal From Takeda - Quick Facts (RTTNews)
21.04.18	Shire Says Considering Its Position On GBP 47.00/shr Proposal From Takeda (RTTNews)
20.04.18	Takeda Raises Offer For Shire To GBP 47.00/shr (RTTNews)
19.04.18	Allergan Says It In Early Stages Of Considering Possible Offer For Shire (RTTNews)
19.04.18	Takeda Says Its GBP 46.50/shr Offer Rejected By Shire, But Talks Continuing (RTTNews)
17.04.18	On World Hemophilia Day 2018, Shire Unites Communities in Asia Pacific and Advocates for 'Principles of Care' (PR Newswire)
07.04.18	Takeda Pharma Confirms Considering Shire Deal (RTTNews)
06.04.18	Nikkei: Takeda Pharma Plans To Acquire Shire In $55 Bln Deal (RTTNews)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
01.04.18	An Ear To The Pharma: 5 Stocks To Watch This Week (RTTNews)
29.03.18	Shire: EMA Validates Marketing Authorization Application For Lanadelumab (RTTNews)
28.03.18	Shire Shares Surge 16% As Takeda Eyes Acquisition Bid - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Shire plc (Spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten